These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 9049678

  • 1. Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Dofetilide Post-CABG Study Group.
    Frost L, Mortensen PE, Tingleff J, Platou ES, Christiansen EH, Christiansen N.
    Int J Cardiol; 1997 Jan 31; 58(2):135-40. PubMed ID: 9049678
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group.
    Nørgaard BL, Wachtell K, Christensen PD, Madsen B, Johansen JB, Christiansen EH, Graff O, Simonsen EH.
    Am Heart J; 1999 Jun 31; 137(6):1062-9. PubMed ID: 10347332
    [Abstract] [Full Text] [Related]

  • 3. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators.
    Falk RH, Pollak A, Singh SN, Friedrich T.
    J Am Coll Cardiol; 1997 Feb 31; 29(2):385-90. PubMed ID: 9014993
    [Abstract] [Full Text] [Related]

  • 4. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ, Markham A.
    Drugs; 1999 Dec 31; 58(6):1043-59. PubMed ID: 10651390
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of dofetilide for the prevention of atrial tachyarrhythmias (atrial fibrillation or flutter) after coronary artery bypass grafting.
    Serafimovski N, Burke P, Khawaja O, Sekulic M, Machado C.
    Am J Cardiol; 2008 Jun 01; 101(11):1574-9. PubMed ID: 18489935
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study.
    Singh S, Zoble RG, Yellen L, Brodsky MA, Feld GK, Berk M, Billing CB.
    Circulation; 2000 Nov 07; 102(19):2385-90. PubMed ID: 11067793
    [Abstract] [Full Text] [Related]

  • 7. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study.
    Bianconi L, Castro A, Dinelli M, Alboni P, Pappalardo A, Richiardi E, Santini M.
    Eur Heart J; 2000 Aug 07; 21(15):1265-73. PubMed ID: 10924317
    [Abstract] [Full Text] [Related]

  • 8. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.
    Køber L, Bloch Thomsen PE, Møller M, Torp-Pedersen C, Carlsen J, Sandøe E, Egstrup K, Agner E, Videbaek J, Marchant B, Camm AJ, Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group.
    Lancet; 2000 Dec 16; 356(9247):2052-8. PubMed ID: 11145491
    [Abstract] [Full Text] [Related]

  • 9. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
    Torp-Pedersen C, Møller M, Bloch-Thomsen PE, Køber L, Sandøe E, Egstrup K, Agner E, Carlsen J, Videbaek J, Marchant B, Camm AJ.
    N Engl J Med; 1999 Sep 16; 341(12):857-65. PubMed ID: 10486417
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of intravenously administered dofetilide in patients with Wolff-Parkinson-White syndrome.
    Krahn AD, Klein GJ, Yee R.
    Pacing Clin Electrophysiol; 2001 Aug 16; 24(8 Pt 1):1258-60. PubMed ID: 11523612
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug.
    Crijns HJ, Van Gelder IC, Kingma JH, Dunselman PH, Gosselink AT, Lie KI.
    Eur Heart J; 1994 Oct 16; 15(10):1403-8. PubMed ID: 7821320
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter.
    Suttorp MJ, Polak PE, van 't Hof A, Rasmussen HS, Dunselman PH, Kingma JH.
    Am J Cardiol; 1992 Feb 01; 69(4):417-9. PubMed ID: 1734660
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter.
    Lindeboom JE, Kingma JH, Crijns HJ, Dunselman PH.
    Am J Cardiol; 2000 Apr 15; 85(8):1031-3. PubMed ID: 10760352
    [No Abstract] [Full Text] [Related]

  • 15. Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease.
    Banchs JE, Baquero GA, Nickolaus MJ, Wolbrette DL, Kelleman JJ, Samii S, Grando-Ting J, Penny-Peterson E, Davidson WR, Young SK, Naccarelli GV, Gonzalez MD.
    Congenit Heart Dis; 2014 Apr 15; 9(3):221-7. PubMed ID: 23947935
    [Abstract] [Full Text] [Related]

  • 16. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.
    Am J Cardiol; 2003 Mar 20; 91(6A):15D-26D. PubMed ID: 12670638
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dofetilide: a new pure class III antiarrhythmic agent.
    Falk RH, Decara JM.
    Am Heart J; 2000 Nov 20; 140(5):697-706. PubMed ID: 11054613
    [Abstract] [Full Text] [Related]

  • 19. A Quarter of a Century Later: What is Dofetilide's Clinical Role Today?
    Wolbrette DL, Hussain S, Maraj I, Naccarelli GV.
    J Cardiovasc Pharmacol Ther; 2019 Jan 20; 24(1):3-10. PubMed ID: 29940780
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.